SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Engström Hans) ;pers:(Persson Hans)"

Sökning: WFRF:(Engström Hans) > Persson Hans

  • Resultat 1-6 av 6
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  •  
4.
  • Malinovschi, Andrei, 1978-, et al. (författare)
  • Assessment of Global Lung Function Initiative (GLI) reference equations for diffusing capacity in relation to respiratory burden in the Swedish CArdioPulmonary bioImage Study (SCAPIS)
  • 2020
  • Ingår i: European Respiratory Journal. - Lausanne, Switzerland : European Respiratory Society (ERS). - 0903-1936 .- 1399-3003. ; 56:2
  • Tidskriftsartikel (refereegranskat)abstract
    • The Global Lung Function Initiative (GLI) has recently published international reference values for diffusing capacity of the lung for carbon monoxide (DLCO). Lower limit of normal (LLN), i.e. the 5th percentile, usually defines impaired DLCO. We examined if the GLI LLN for DLCO differs from the LLN in a Swedish population of healthy, never-smoking individuals and how any such differences affect identification of subjects with respiratory burden.Spirometry, DLCO, chest high-resolution computed tomography (HRCT) and questionnaires were obtained from the first 15 040 participants, aged 50–64 years, of the Swedish CArdioPulmonary bioImage Study (SCAPIS). Both GLI reference values and the lambda-mu-sigma (LMS) method were used to define the LLN in asymptomatic never-smokers without respiratory disease (n=4903, of which 2329 were women).Both the median and LLN for DLCO from SCAPIS were above the median and LLN from the GLI (p<0.05). The prevalence of DLCO DLCO >GLI LLN but DLCO >GLI LLN but versus 4.5%, p<0.001), chronic airflow limitation (8.5% versus 3.9%, p<0.001) and chronic bronchitis (8.3% versus 4.4%, p<0.01) than subjects (n=13 600) with normal DLCO (>GLI LLN and >SCAPIS LLN). No differences were found with regard to physician-diagnosed asthma.The GLI LLN for DLCO is lower than the estimated LLN in healthy, never-smoking, middle-aged Swedish adults. Individuals with DLCO above the GLI LLN but below the SCAPIS LLN had, to a larger extent, an increased respiratory burden. This suggests clinical implications for choosing an adequate LLN for studied populations.
  •  
5.
  • Mohammad, Moman A., et al. (författare)
  • Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality : a Swedish nationwide observational study
  • 2017
  • Ingår i: EuroIntervention. - : Europa Edition. - 1774-024X .- 1969-6213. ; 13:2, s. E210-E218
  • Tidskriftsartikel (refereegranskat)abstract
    • Aims: Our aim was to investigate the impact of intravenous (IV) beta-blocker therapy on short-term mortality and other in-hospital events in patients with ST-segment elevation myocardial infarction (STEMI) treated with dual antiplatelet therapy (DAPT) and primary percutaneous coronary intervention (PCI).Methods and results: Using the nationwide Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) registry, we identified all patients with STEMI undergoing PCI between 2006 and 2013. Patients with cardiogenic shock and cardiac arrest at presentation were excluded. The primary endpoint was mortality within 30 days. Secondary endpoints were in-hospital events (mortality, cardiogenic shock and left ventricular ejection fraction [LVEF] <40% at discharge). We adjusted for confounders with a multivariable model and propensity score matching. Out of 16,909 patients, 2,876 (17.0%) were treated with an IV beta-blocker. After adjusting for confounders, the IV beta-blocker group had higher 30-day all-cause mortality (HR: 1.44, 95% CI: 1.14-1.83), more in-hospital cardiogenic shock (OR: 1.53, 95% CI: 1.09-2.16) and were more often discharged with an LVEF <40% (OR: 1.70, 95% CI: 1.51-1.92).Conclusions: In this large nationwide observational study, the use of IV beta-blockers in patients with STEMI treated with primary PCI was associated with higher short-term mortality, lower LVEF at discharge, as well as a higher risk of in-hospital cardiogenic shock.
  •  
6.
  • Skoglundh, Magnus, 1965, et al. (författare)
  • An investigation of the NOx storage mechanism
  • 1998
  • Ingår i: American Vacuum Society 45th International Symposium in Baltimore, Maryland, USA, November 2-6, 1998..
  • Konferensbidrag (refereegranskat)
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-6 av 6
Typ av publikation
tidskriftsartikel (3)
konferensbidrag (3)
Typ av innehåll
refereegranskat (6)
Författare/redaktör
Engström, Per (4)
Fridell, Erik, 1963 (3)
Skoglundh, Magnus, 1 ... (3)
Kasemo, Bengt Herber ... (3)
Amberntsson, Annika, ... (2)
visa fler...
Ljungström, Sten, 19 ... (2)
Cruise, Neil, 1969 (2)
Engström, Gunnar (1)
Wollmer, Per (1)
Fröbert, Ole, 1964- (1)
Janson, Christer (1)
Bergström, Göran, 19 ... (1)
Torén, Kjell, 1952 (1)
Malinovschi, Andrei, ... (1)
Westerberg, Björn, 1 ... (1)
Johansson, Stefan, 1 ... (1)
Erlinge, David (1)
Engvall, Jan (1)
Caidahl, Kenneth, 19 ... (1)
Koul, Sasha (1)
Blomberg, Anders, 19 ... (1)
Jensen, Jens (1)
Engstrøm, Thomas (1)
Jernberg, Tomas (1)
Brisman, Jonas, 1954 (1)
Lindberg, Anne (1)
Bake, Björn, 1939 (1)
Andell, Pontus (1)
Mohammad, Moman A. (1)
Omerovic, Elmir (1)
Andersson, Bengt, 19 ... (1)
Mannila, Maria (1)
Vikgren, Jenny, 1957 (1)
Eriksson, Maria J. (1)
Östgren, Carl Johan (1)
Spaak, Jonas (1)
Zhou, Xingwu (1)
Hofman-Bang, Claes (1)
Desta, Liyew (1)
Sköld, C Magnus (1)
Linder, Robert, 1981 ... (1)
Johansson, Louise (1)
Frølich, Andreas (1)
Jansson, Kjell, 1956 ... (1)
Persson, Hans L. (1)
visa färre...
Lärosäte
Chalmers tekniska högskola (4)
Lunds universitet (2)
Karolinska Institutet (2)
Göteborgs universitet (1)
Umeå universitet (1)
Uppsala universitet (1)
visa fler...
Örebro universitet (1)
Linköpings universitet (1)
visa färre...
Språk
Engelska (6)
Forskningsämne (UKÄ/SCB)
Teknik (4)
Medicin och hälsovetenskap (2)
Naturvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy